Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa, 2014–2018
Sarah E. Schmedes
1, Dhruviben Patel
1, Simran Dhal, Julia Kelley, Samaly S. Svigel, Pedro Rafael Dimbu, Adicatou-Laï Adeothy, Gauthier Mesia Kahunu, Papy Mandoko Nkoli, Abdoul Habib Beavogui, Simon Kariuki, Don P. Mathanga, Ousmane Koita, Deus Ishengoma, Ally Mohamad, Moonga Hawela, Leah F. Moriarty, Aaron M. Samuels, Julie Gutman, Mateusz M. Plucinski, Venkatachalam Udhayakumar, Zhiyong Zhou, Naomi W. Lucchi, Meera Venkatesan, Eric S. Halsey, and Eldin Talundzic
Author affiliations: Association of Public Health Laboratories, Silver Spring, Maryland, USA (S.E. Schmedes); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.E. Schmedes, D. Patel, S.S. Svigel, A.M. Samuels, J. Gutman, M.M. Plucinski, V. Udhayakumar, Z. Zhou, N.W. Lucchi, E. Talundzic); Williams Consulting LLC, Baltimore, Maryland, USA (D. Patel); The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta (S. Dahl); CDC Foundation, Atlanta (J. Kelley); National Malaria Control Program, Ministry of Health, Luanda, Angola (P.R. Dimbu); National Malaria Control Program, Ministry of Health, Porto-Novo, Benin (A.-L. Adeothy); University of Kinshasa, Kinshasa, Democratic Republic of the Congo (G.M. Kahunu); National Institute of Biomedical Research, Kinshasa (P.M. Nkoli); Maferinyah Rural Health Research Center, Mafèrinyah, Guinea (A.H. Beavogui); Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya (S. Kariuki); University of Malawi College of Medicine, Blantyre, Malawi (D.P. Mathanga); University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali (O. Koita); Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA (D. Ishengoma); National Institute for Medical Research, Tanga Research Centre, Dar es Salaam, Tanzania (D. Ishengoma, A. Mohamad); Monash University Faculty of Pharmaceutical Sciences, Melbourne, Australia (D. Ishengoma); National Malaria Elimination Centre, Lusaka, Zambia (M. Hawela); US President’s Malaria Initiative, Centers for Disease Control and Prevention, Atlanta (L.F. Moriarty, M.M. Plucinski, E.S. Halsey); US President’s Malaria Initiative, US Agency for International Development, Washington, DC, USA (M. Venkatesan)
Main Article
Table 3
Summary of Pfk13 gene mutations detected in Plasmodium falciparum pretreatment and DF samples, 9 countries in Africa, 2014–2018*
|
No. samples pretreatment (DF)
|
Country (year) |
Total with sequencing attempted |
Poor quality or no amplification |
Successfully sequenced |
Wild-type samples pretreatment |
Other nonsynonymous mutations |
Synonymous mutations |
Angola (2015) |
379 (0) |
77 (0) |
302 (0) |
291 (0) |
5 (0) |
6 (0) |
Angola (2017) |
38 (38) |
0 (2) |
38 (36) |
37 (36) |
1 (0) |
0 (0) |
Benin (2017) |
175 (19) |
20 (1) |
155 (18) |
151 (18) |
1 (0) |
3 (0) |
DRC (2017–2018) |
317 (316) |
13 (34) |
304 (282) |
295 (269) |
1 (2) |
8 (11) |
Guinea (2016) |
409 (23) |
20 (1) |
389 (22) |
380 (22) |
1 (0) |
8 (0) |
Kenya (2016–2017) |
325 (92) |
7 (4) |
318 (88) |
302 (85) |
8 (2) |
8 (1) |
Malawi (2014) |
8 (19) |
1 (5) |
7 (14) |
7 (14) |
0 (0) |
0 (0) |
Mali (2015–2016) |
320 (90) |
68 (48) |
252 (42) |
244 (39) |
1 (0) |
7 (3) |
Tanzania (2016) |
345 (72) |
20 (12) |
325 (60) |
306 (57) |
6 (0) |
13 (3) |
Zambia (2016)
|
263 (0)
|
50 (0)
|
213 (0)
|
200 (0)
|
1 (0)
|
12 (0)
|
Total |
2,579 (669) |
276 (107) |
2,303 (562) |
2,213 (540) |
25 (4) |
65 (18) |
Main Article
Page created: April 28, 2021
Page updated: June 16, 2021
Page reviewed: June 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.